Ocugen Inc. (OCGN) |
|
2.22 0.04 (1.83%)
|
01-17 17:33 |
|
Open: |
2.26 |
Pre. Close: |
2.18 |
|
High:
|
2.3782 |
Low:
|
2.12 |
|
Volume:
|
17,853,797 |
Market Cap:
|
360M |
|
|
|
|
Ocugen, Inc. engages in the development and commercialization of therapies for eye diseases. The company is headquartered in Malvern, Pennsylvania and currently employs 49 full-time employees. The firm offers a diversified ophthalmology portfolio that includes gene therapies, biologics, and small molecules and targets a range of retinal and ocular surface diseases. The firm is leveraging its modifier gene therapy platform to address genetically diverse inherited retinal disorders and dry age-related macular degeneration (AMD), based on nuclear hormone receptor genes NR2E3 (OCU400) and RORA (OCU410), respectively. The firm is also developing biologic therapies for wet-AMD, diabetic macular edema (DME) and diabetic retinopathy (OCU200), as well as for retinitis pigmentosa (OCU100). |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
2.382 - 2.399 |
2.399 - 2.412 |
|
Low:
|
2.091 - 2.108 |
2.108 - 2.12 |
|
Close:
|
2.198 - 2.224 |
2.224 - 2.244 |
|
Technical analysis |
as of: 2021-01-15 4:43:48 PM |
|
Overall:
|
 |
| Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
| Target: |
Six months: 4.09 One year: 4.77 |
| Support: |
Support1: 1.51 Support2: 0.28 |
| Resistance: |
Resistance1: 3.50 Resistance2: 4.09 |
| Pivot: |
2.37  |
| Moving Average: |
MA(5): 2.32 MA(20): 1.99 
MA(100): 0.65 MA(250): 0.49 |
| MACD: |
MACD(12,26): 0.46 Signal(9): 0.52 |
| Stochastic oscillator: |
%K(14,3): 43.37 %D(3): 53.91 |
| RSI: |
RSI(14): 57.00 |
| 52-week: |
High: 3.50 Low: 0.17 Change(%): 221.7 |
| Average Vol(K): |
3-Month: 4914205 10-Days: 4904364 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.OCGN has closed above bottom band by 39.7%. Bollinger Bands are 148.6% wider than normal. The large width of the bands suggest high volatility as compared to OCGN's normal range. The bands have been in this wide range for 16 bars. This is a sign that the current trend might continue. |
|
|
Headline News |
Fri, 15 Jan 2021
Premarket Mover: Ocugen Inc (OCGN) Up 4.59% - InvestorsObserver
Thu, 14 Jan 2021
Do Traders View Ocugen Inc (OCGN) Stock's Current Trend Positively? - InvestorsObserver
Wed, 13 Jan 2021
Ocugen climbs after management indicated positive events - Seeking Alpha
Wed, 13 Jan 2021
Should You Buy Ocugen Inc (OCGN) Stock Wednesday? - InvestorsObserver
Tue, 12 Jan 2021
Ocugen Inc. Announces the Cancellation of Stockholder Meeting Previously Adjourned to 11:00 a.m. Eastern Time on January 13, 2021 - GlobeNewswire
Fri, 08 Jan 2021
Ocugen Inc. Regains Compliance with Nasdaq Bid Price Rule - GlobeNewswire
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
n/a |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Outperform |
Discounted cash flow: |
Outperform |
| Return on Assets: |
Underperform |
Price to Earnings: |
Underperform |
| Return on Equity: |
Underperform |
Debt to Equity: |
Neutral |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
162 |
| Shares Float (M) |
156 |
|
% Held by Insiders
|
3.26 |
|
% Held by Institutions
|
13.12 |
|
Shares Short (K)
|
4,980 |
|
Shares Short P. Month (K)
|
5,140 |
Stock Financials |
|
EPS
|
|
|
EPS Est This Year
|
|
|
EPS Est Next Year
|
|
|
Book Value (p.s.)
|
|
|
Profit Margin
|
|
|
Operating Margin
|
-32042.68 |
|
Return on Assets (ttm)
|
-38.7 |
|
Return on Equity (ttm)
|
-850.6 |
|
Qtrly Rev. Growth
|
|
|
Gross Profit (p.s.)
|
|
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
-0.084 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-19 |
|
Levered Free Cash Flow (M)
|
-34 |
Stock Valuations |
|
PE Ratio
|
|
|
PEG Ratio
|
|
|
Price to Book value
|
|
|
Price to Sales
|
8439.85 |
|
Price to Cash Flow
|
-18.76 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
